Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 known ✓ | P31645 | 14/20 | 0.59 |
| ▸ | SLC6A2 known ✓ | P23975 | 8/20 | 0.49 |
| ▸ | KCNH2 known ✓ | Q12809 | 3/20 | 0.49 |
| ▸ | KMT2A known ✓ | Q03164 | 2/20 | 0.49 |
| ▸ | HTR2A known ✓ | P28223 | 2/20 | 0.49 |
| ▸ | HTR2C known ✓ | P28335 | 2/20 | 0.49 |
| ▸ | HRH1 known ✓ | P35367 | 2/20 | 0.49 |
| ▸ | HTR2B known ✓ | P41595 | 2/20 | 0.49 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.49 |
| ▸ | NOS2 | P35228 | 3/20 | 0.80 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.49 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.49 |
| ▸ | DRD3 | P35462 | 2/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL6501362 | 1.00 | NOS2 (0.80) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| SCHEMBL6497740 | 0.91 | NOS2 (0.77) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| SCHEMBL6497746 | 0.91 | NOS2 (0.77) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| Fumaric Acid SCHEMBL6491175 | 0.89 | NOS2 (1.00) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| Fumaric Acid SCHEMBL6491990 | 0.89 | NOS2 (1.00) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| Fumaric Acid SCHEMBL6501568 | 0.85 | NOS2 (0.76) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| Fumaric Acid SCHEMBL6501560 | 0.85 | NOS2 (0.76) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| SCHEMBL6492848 | 0.79 | NOS2 (1.00) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| SCHEMBL6492851 | 0.79 | NOS2 (1.00) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 | |
| Fumaric Acid SCHEMBL6502146 | 0.79 | NOS2 (0.61) | NOS2SLC6A4SLC6A2CYP2D6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6887871-B2 | Use of phenylheteroakylamine derivatives | ASTRAZENECA AB (SE) | 2005-05-03 | — | — | US | disclosed |
| US-20030158185-A1 | Novel use of phenylheteroakylamine derivatives | ASTRAZENECA AB (SE) | 2003-08-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030158185-A1 | Novel use of phenylheteroakylamine derivatives | NOS1, XDH, NOS2 | SLC6A4 2468/4885SLC6A2 1776/4885KCNH2 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.